Keywords: strong, net, profits, growth, sankyo, pharmaceutical, japan
Strong net profits growth for Sankyo
Article | 24 May 1999
Sankyo Pharmaceutical, Japan's second-largest drugmaker, reported salesdown 0.2% to 463 billion yen ($3.75 billion) but net profits saw a 9.5% rise to 67.9 billion yen ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
